The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic therapy in NF-1 associated malignant peripheral nerve sheath tumors (MPNST).
 
Pujita Munnangi
No Relationships to Disclose
 
Bridgette L King
No Relationships to Disclose
 
Y. Sabrina Chiang
No Relationships to Disclose
 
Anthony Paul Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst)
Travel, Accommodations, Expenses - Genentech
 
Dejka M. Araujo
Research Funding - Adaptimmune (Inst); GlaxoSmithKline (Inst); Immatics (Inst)
 
J. Andrew Livingston
Consulting or Advisory Role - SpringWorks Therapeutics
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Repare Therapeutics (Inst)
Other Relationship - Guidepoint Global
 
Joseph Aloysius Ludwig
Research Funding - Boehringer Ingelheim (Inst); Ikena Oncology (Inst)
 
Michael Nakazawa
Research Funding - Repare Therapeutics (Inst)
 
Elise F Nassif Haddad
Honoraria - Sonata Therapeutics
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Honoraria - UpToDate
Consulting or Advisory Role - AADi; Daiichi Sankyo; Daiichi Sankyo; Deciphera; Deciphera; Gerson Lehrman Group; Guidepoint Inc
Research Funding - AADi (Inst); Athenex (Inst); Deciphera (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Ravin Ratan
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Medtronic (I)
Honoraria - Peerview; touchIME
Consulting or Advisory Role - Epizyme; InhibRx
Research Funding - Ayala Pharmaceuticals (Inst); Bayer; C4 Therapeutics (Inst); Epizyme; SpringWorks Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - SpringWorks Therapeutics; SpringWorks Therapeutics
 
Maria Alejandra Zarzour
No Relationships to Disclose
 
Shreyaskumar Patel
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Rain Oncology
Research Funding - PTC Therapeutics; Rain Therapeutics (Inst)
 
Keila E Torres
No Relationships to Disclose
 
Neeta Somaiah
Stock and Other Ownership Interests - JNJ (I); Pfizer (I)
Consulting or Advisory Role - AADi; Bayer; Blueprint Medicines; Boehringer Ingelheim; Deciphera; Epizyme
Research Funding - Advenc; Ascentage Pharma; AstraZeneca/MedImmune (Inst); Cogent Biosciences; Daiichi Sankyo/Lilly; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics